| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.17B | +50.5% |
| Cost of Revenue | $1.73B | +55.9% |
| Gross Profit | $437.6M | +32.5% |
| R&D Expense | $26.6M | +31.0% |
| SG&A Expense | $266.1M | +56.6% |
| Operating Income | $51.4M | -38.3% |
| Interest Expense | $86.1M | +86.8% |
| Pre-tax Income | -$24.4M | +7.9% |
| Income Tax | -$12.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $124.4M | +66.5% |
| Accounts Receivable | $266.8M | +12.1% |
| Inventory | $534.9M | +106.1% |
| Current Assets | $974.7M | +63.9% |
| Total Assets | $3.67B | +51.6% |
| Current Liabilities | $466.1M | +101.7% |
| Long-term Debt | $1.72B | +34.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $202.2M | +248.0% |
| Capital Expenditures | $56.9M | +58.5% |
| Investing Cash Flow | -$481.3M | +24.4% |
| Financing Cash Flow | $331.6M | -44.7% |
| Free Cash Flow | $145.3M | +554.5% |
| -34.0% |
| Net Income | -$6.6M | -107.4% |
| EPS (Basic) | -$0.18 | -106.4% |
| EPS (Diluted) | -$0.18 | -106.4% |
| Total Liabilities |
| $2.49B |
| +43.3% |
| Stockholders' Equity | $1.18B | +72.9% |